Not Yet Operational
Medical cannabis products are defined explicitly as a “tablet,” “capsule,” “a concentrated oil,” “a liquid suspension,” “a topical preparation,” “a transdermal preparation,” “a sublingual preparation,” “a gelatinous cube or lozenge,” or “a blister pack of unprocessed cannabis flower.” All products must be labeled with a bar code. Patients may obtain up to a 14-day supply of medical cannabis products.
No. Replacement legislation approved by the House and Senate on December 3, 2018 rewrote the Utah Medical Cannabis Act to eliminate any home cultivation option. Proponents of the voter-initiated measure are suing over the changes.
Yes, but they are defined as ‘medical pharmacies’ under the replacement legislation. Regulators may issue no more than seven medical pharmacy licenses.
Yes. Patients may designate no more than two caregivers, who may purchase, transport, or assist the patient in his/her use of medical cannabis in a dosage form.
Text of the replacement bill, House Bill 3001, is online here.